Study of Lenalidomide (Revlimid) in Patients With Relapsed/Refractory Peripheral T-cell Lymphoma (PTCL) Patients.
Phase of Trial: Phase II
Latest Information Update: 24 Aug 2012
At a glance
- Drugs Lenalidomide (Primary)
- Indications Peripheral T-cell lymphoma
- Focus Adverse reactions
- 01 Aug 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 29 Dec 2009 New trial record